DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

(2012) Jian Zhu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine

(2011) Tahlita C.M. Zuiverloon et al.   BJU INTERNATIONAL

Methylation profiling of rectal cancer identifies novel markers of early-stage disease

(2011) K. J. Leong et al.   BRITISH JOURNAL OF SURGERY

Aberrant Methylation of RAR 2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer

(2011) S. Eissa et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer

(2011) Maria José Cabello et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer

(2011) Cathy B Moelans et al.   JOURNAL OF PATHOLOGY

Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events

(2010) Reza R. Serizawa et al.   INTERNATIONAL JOURNAL OF CANCER

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

(2010) Mónica Castro et al.   Journal of Translational Medicine

Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection

(2010) Hui-Hui Lin et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Mechanisms of recurrence of Ta/T1 bladder cancer

(2010) Richard T Bryan et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Epigenetics in cancer

(2009) S. Sharma et al.   CARCINOGENESIS

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma

(2009) Tao Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways

(2009) Marija Pljesa-Ercegovac et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection

(2008) Priscilla D Negraes et al.   BMC CANCER

Epigenetic Signatures of Familial Cancer Are Characteristic of Tumor Type and Family Category

(2008) E. I. Joensuu et al.   CANCER RESEARCH

HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors

(2008) Capucine Fleuriel et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Epigenetic markers as promising prognosticators for bladder cancer

(2008) Young Kyoon Kim et al.   INTERNATIONAL JOURNAL OF UROLOGY

Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer

(2007) Mohammad Obaidul Hoque et al.   JOURNAL OF UROLOGY